LP
Lee's Pharmaceutical Holdings Limited
LPCUF · OTC
$0.19 -1.10% (-$0.00)
Market Cap $879.2M
P/E Ratio 9.56x
Div. Yield 3.07%
ROE 4.51%
Bulios Fair Price
$0.11
41.6% downside
Current Price
$0.19
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LPCUF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
9/9Valuation
100 /100
Cheap P/E 9.56x
P/FCF 8.67x
EV/EBITDA 3.87x
Growth
68 /100
Growing EPS growth 22.47%
Book val. growth 2.06%
Rev. growth 5.20%
Profitability
50 /100
Moderate Gross margin 50.81%
FCF margin 7.06%
Net margin 6.40%
Quality
17 /100
Poor ROIC 1.67%
Asset turnover 0.41x
ROE 4.51%
Debt
83 /100
Low Debt/Equity 0.15x
Net debt/EBITDA -0.18x
Current ratio 1.03x
Stability
53 /100
Moderate Beta 0.60x
Profitable years 6
Rev. volatility 24.08%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LPCUF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Wanee Leelalertsuphakun
Employees
1,094
Headquarters
Hong Kong
Upcoming events
25 SEP
Ex-Dividend
Ex-dividend date
16 OCT
Dividend Payment
Payment date